» Authors » Caroline Stigant

Caroline Stigant

Explore the profile of Caroline Stigant including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 33
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sandal S, El Wazze S, Nijjar D, Ethier I, Paparella A, Hales L, et al.
J Am Soc Nephrol . 2025 Feb; PMID: 39913200
Background: Natural, technological and other disasters cause significant human suffering, and kidney patients are uniquely vulnerable. The safe provision of kidney replacement therapies necessitates the consistent provision of resources. Robust...
2.
Verdin N, Black A, Stigant C
Can J Kidney Health Dis . 2025 Jan; 12():20543581241308642. PMID: 39822349
No abstract available.
3.
Ethier I, Sandal S, Tarakji A, Finkle S, Kahlon B, Pederson K, et al.
Can J Kidney Health Dis . 2024 Oct; 11:20543581241287286. PMID: 39386276
Background: Climate change impacts health and threatens the stability of care delivery systems, while healthcare is mobilizing to reduce its significant environmental impact. Objective: This study aimed to assess knowledge,...
4.
Rao N, Rajan T, Stigant C
Kidney Int Rep . 2023 Feb; 8(2):365-367. PMID: 36815104
No abstract available.
5.
Rajan T, Amin S, Davis K, Finkle N, Glick N, Kahlon B, et al.
Can J Kidney Health Dis . 2022 Aug; 9:20543581221116215. PMID: 35966172
Climate change is one of the greatest threats to human health in the 21st century. The human health impacts of climate change contribute to approximately 1 in 4 deaths worldwide....
6.
Stigant C
Can J Kidney Health Dis . 2022 Jul; 9:20543581221102042. PMID: 35847177
No abstract available.
7.
Mailman J, Stigant C, Martinusen D
Ann Pharmacother . 2014 Apr; 48(7):919-922. PMID: 24687544
Objective: To alert clinicians to a serious complication from a commonly prescribed medication, moxifloxacin. Case Summary: A 65-year-old male, septic, hemodialysis patient developed thrombocytopenia following exposure to vancomycin, ceftazidime, and...
8.
Stigant C, Izadnegahdar M, Levin A, Buller C, Humphries K
Am J Kidney Dis . 2005 Jun; 45(6):1002-9. PMID: 15957128
Background: Percutaneous coronary intervention (PCI) with stenting reduces adverse events in the general population compared with balloon angioplasty. The benefit of stents in high-risk patients normally excluded from clinical trials...
9.
Stigant C, Stevens L, Levin A
CMAJ . 2003 Jun; 168(12):1553-60. PMID: 12796336
No abstract available.
10.
Stevens L, Stigant C, Levin A
Semin Dial . 2002 Mar; 15(1):8-13. PMID: 11874582
In the last decade the nephrology community has learned much about the impact of anemia on patients with kidney disease. Therapy of anemia can correct many of the symptoms which...